Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial Acute.

Slides:



Advertisements
Similar presentations
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Advertisements

Date of download: 7/8/2016 From: Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease Ann Intern Med. Published.
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Volume 385, Issue 9985, Pages (June 2015)
NORSTENT Trial design: Patients with obstructive coronary artery disease were randomized to a drug-eluting stent (DES) (n = 4,504) versus a bare-metal.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
Survival probability (%)
Figure 1 The flowchart depicts the total number of procedures in the Western Denmark Heart Registry (WDHR) and the exclusion of patients; NPR, National.
Successful CTO PCI Associated with Lower Mortality Risk
Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /
Impella 2.5® Device Is Associated with Improved Survival in AMICS
(CMR vs. guidelines, p < 0.001)
 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.
DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)
EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.
GLAGOV Trial design: Patients with CAD and elevated LDL cholesterol on statin therapy were randomized to subcutaneous evolocumab (n = 484) vs. subcutaneous.
Volume 89, Issue 6, Pages (June 2016)
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Acute kidney injury and chronic kidney disease
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
One or Two Internal Thoracic Grafts
MACE rate among CAD severity groups (total 0
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Propofol as a panacea for acute kidney injury?
Coronary revascularisation rate (total 5
AMACING Trial design: Patients with chronic kidney disease undergoing intravascular iodinated contrast administration were randomized to prophylactic hydration.
(p < for noninferiority)
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.
Effectiveness of Contrast-enhanced MR Angiography for Visualization of the Prostatic Artery prior to Prostatic Arterial Embolization Contrast-enhanced.
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
(p = for noninferiority)
Volume 385, Issue 9985, Pages (June 2015)
CT Angiography of the Aorta: Contrast Timing by Using a Fixed versus a Patient-specific Trigger Delay In 108 participants undergoing CT angiography of.
Renal Replacement Therapy in Acute Kidney Injury
Patient Preferences for Coronary CT Angiography with Stress Perfusion, SPECT, or Invasive Coronary Angiography Our intraindividual comparison in 16 sites.
Diagnostic Performance of Four-dimensional CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism Combined four-dimensional.
Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.
Flow Diagram of the Trial Selection Process
Cardiovascular complications in chronic kidney disease
Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.
Deep Learning for Diagnosis of Chronic Myocardial Infarction on Nonenhanced Cardiac Cine MRI Deep learning to identify myocardial infarction on nonenhanced.
Low-Energy and Low-Tube-Current CT for Positive Oral Contrast Media in Patients with Cancer: A Randomized Clinical Trial At low tube current or low energy.
SOLID-TIMI 52 Trial design: Participants within 30 days of an acute coronary syndrome (ACS) were randomized to darapladib 160 mg daily (n = 6,504) versus.
Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.
Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation.
Kaplan–Meier survival curve for major adverse cardiac events (MACE): a trend towards superior survival in patients without signs of coronary artery disease.
Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.
Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.
MATRIX: Radial vs. Femoral
Glenn N. Levine et al. JACC 2011;58:e44-e122
Flow chart of the cohort selection for the study
A: Kaplan-Meier curves depicting the cumulative probability of CVE in patients with low (
Stavros V. Konstantinides et al. JACC 2017;69:
Scoring of Coronary Artery Disease Characteristics on Coronary CT Angiograms by Using Machine Learning For prediction of all-cause mortality on the basis.
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher.
Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:
Reproducibility and Changes in Vena Caval Blood Flow by Using Four-dimensional Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease:
Michael Reed et al. JCIN 2009;2:
Kaplan-Meier survival curve for all catheterisations.
 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.
Left Ventricular Mass at MRI and Long-Term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Left ventricular hypertrophy.
Altered Vascular Permeability in Migraine-associated Brain Regions: Evaluation by Dynamic Contrast-enhanced MRI Participants with migraine exhibited lower.
Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.
Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.
Kaplan-Meier curve for the probability of noninvasive ventilation (NIV) failure relative to continuous use of NIV and stratified for Acute Physiology and.
First Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies Bird S et al. Published Online: August.
The Ottawa COPD (chronic obstructive pulmonary disease) Risk Scale (OCRS) is used in the emergency department (ED) to identify patients with acute COPD.
 Kaplan-Meier survival curves by severity of exacerbations in patients with COPD: (1) no acute exacerbations of COPD; (2) patients with acute exacerbations.
Presentation transcript:

Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial Acute kidney injury was more likely after intra-arterial (s/p cardiac catheterization) than after intravenous (s/p CTA) contrast agent administration (13.2% vs 5.6%, respectively; relative risk, 2.4; P = .02). For individuals without obstructive CAD, acute kidney injury was more common in the catheterization group than in the CTA group (11.9% vs 4.3%; P = .02). Chronic kidney disease was more likely in individuals who had postcontrast acute kidney injury (12-fold greater risk, P < .01). Kaplan-Meier curve shows a lower probability of acute kidney injury in the intravenous CTA group compared with the intra-arterial contrast agent group. Schönenberger E et al. Published Online: July 2, 2019 https://doi.org/10.1148/radiol.2019182220